Lanzamiento Enero 2027

Ensayo controlado aleatorizado2013Acceso abierto

Prenatal vitamin d supplementation and child respiratory health: a randomised controlled trial

Goldring ST, Griffiths CJ, Martineau AR, Robinson S, Yu C, Poulton S, Kirkby JC, Stocks J, Hooper R, Shaheen SO, Warner JO, Boyle RJ

PloS one · 130 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Eventos clínicos como enfermedad o muerte

Quién lo pagó

Financiación
Financiación independiente
Gobierno
National Institute for Health and Care Research
Organización sin fines de lucro
Asthma and Lung UK
Universidad u hospital
Imperial College London
Gobierno
National Institute for Health Research (NIHR)
Gobierno
Medical Research Council
Subvenciones
National Institute for Health and Care Research (NF-SI-0509-10171)

Según 5 financiadores declarados y la declaración de financiación del texto completo.

Publicación

Publicado
2013-06-24 · PLoS One · vol. 8 · número 6 · pág. e66627
Editorial
Public Library of Science
Citado
176 citas · más que el 99% de estudios similares · 13.1× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
34 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
Vitamin D Research Studies · Asthma and respiratory diseases · Birth, Development, and Health
Palabras clave
prenatal vitamin D supplementation, childhood wheezing, vitamin D status, cord blood vitamin D, atopy, serum IgE, exhaled nitric oxide, lung function, respiratory infections, atopic dermatitis
MeSH
humans, respiratory tract infections, hypersensitivity, respiratory sounds, nitric oxide, vitamin d, immunoglobulin e, breath tests, prenatal care, pregnancy, dietary supplements, child, preschool, female, male

12 autores

  • Stephen Goldring🇬🇧Imperial College London
  • Chris J Griffiths🇬🇧Queen Mary University of London
  • Adrian R. Martineau🇬🇧Queen Mary University of London
  • Stephen Robinson🇬🇧Imperial College London
  • Chang-Sik Yu🇬🇧Imperial College London
  • Sheree Poulton🇬🇧Imperial College London
  • Jane C. Kirkby🇬🇧University College London
  • Janet Stocks🇬🇧University College London
  • Richard Hooper🇬🇧Queen Mary University of London
  • Seif O. Shaheen🇬🇧Queen Mary University of London
  • John O. Warner🇬🇧Imperial College London
  • Robert J. Boyle🇬🇧 · autor de correspondenciaImperial College London

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Observational studies suggest high prenatal vitamin D intake may be associated with reduced childhood wheezing. We examined the effect of prenatal vitamin D on childhood wheezing in an interventional study.

Methods

We randomised 180 pregnant women at 27 weeks gestation to either no vitamin D, 800 IU ergocalciferol daily until delivery or single oral bolus of 200,000 IU cholecalciferol, in an ethnically stratified, randomised controlled trial. Supplementation improved but did not optimise vitamin D status. Researchers blind to allocation assessed offspring at 3 years. Primary outcome was any history of wheeze assessed by validated questionnaire. Secondary outcomes included atopy, respiratory infection, impulse oscillometry and exhaled nitric oxide. Primary analyses used logistic and linear regression.

Results

We evaluated 158 of 180 (88%) offspring at age 3 years for the primary outcome. Atopy was assessed by skin test for 95 children (53%), serum IgE for 86 (48%), exhaled nitric oxide for 62 (34%) and impulse oscillometry of acceptable quality for 51 (28%). We found no difference between supplemented and control groups in risk of wheeze [no vitamin D: 14/50 (28%); any vitamin D: 26/108 (24%) (risk ratio 0.86; 95% confidence interval 0.49, 1.50; P = 0.69)]. There was no significant difference in atopy, eczema risk, lung function or exhaled nitric oxide between supplemented groups and controls.

Conclusion

Prenatal vitamin D supplementation in late pregnancy that had a modest effect on cord blood vitamin D level, was not associated with decreased wheezing in offspring at age three years.

Trial registration

Controlled-Trials.com ISRCTN68645785.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.